Search Results - Clinical+Specialty+%3e+Orphan+Diseases

1 Results Sort By:
PARP-1 Inhibitor Nanoparticle and Treatment Method for Ewing Sarcoma
A novel nanoparticle formulation of an existing PARP-1 inhibitor and an associated administration regimen has been developed for the treatment of Ewing Sarcoma. This technology allows the therapeutic treatment to be targeted to the tumors, resulting in reduced required doses and system toxicity.Background:Ewing Sarcoma is rare cancer of the bone that...
Published: 12/7/2023   |   Inventor(s): Raushan Kurmasheva, Kytai Nguyen
Keywords(s):  
Category(s): Clinical Specialty > Orphan Diseases, Clinical Specialty > Orthopedics, Therapeutics > Nanoparticles, Clinical Specialty > Oncology, Therapeutics > Small Molecule